Ocean Biomedical Valuation
| OCEA Stock | 0.69 0.02 2.82% |
Ocean Biomedical is undervalued. Ocean Biomedical holds a recent Real Value of USD4.87 per share. The prevailing price of the company is USD0.69. Our model determines the value of Ocean Biomedical from analyzing the company fundamentals such as Shares Owned By Insiders of 71.98 %, number of shares shorted of 167.54 K, and Return On Asset of -6.82 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Ocean Biomedical's valuation include:
Price Book 100.6724 | Enterprise Value 36.9 M | Enterprise Value Ebitda (9.48) |
Undervalued
Today
Please note that Ocean Biomedical's price fluctuation is relatively risky at this time. Calculation of the real value of Ocean Biomedical is based on 3 months time horizon. Increasing Ocean Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ocean Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ocean Stock. However, Ocean Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.69 | Real 4.87 | Target 17.45 | Hype 0.7 | Naive 0.77 |
The real value of Ocean Stock, also known as its intrinsic value, is the underlying worth of Ocean Biomedical Company, which is reflected in its stock price. It is based on Ocean Biomedical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ocean Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ocean Biomedical helps investors to forecast how Ocean stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ocean Biomedical more accurately as focusing exclusively on Ocean Biomedical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Ocean Biomedical's intrinsic value based on its ongoing forecasts of Ocean Biomedical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Ocean Biomedical's closest peers. If more than one evaluation category is relevant for Ocean Biomedical we suggest using both methods to arrive at a better estimate.
Ocean Biomedical Cash |
|
Ocean Valuation Trend
Comparing Ocean Biomedical's enterprise value against its market capitalization is a good way to estimate the value of Ocean Biomedical uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Ocean Biomedical Total Value Analysis
Ocean Biomedical is now forecasted to have valuation of 36.87 M with market capitalization of 25.64 M, debt of 12.12 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Ocean Biomedical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
36.87 M | 25.64 M | 12.12 M |
Ocean Biomedical Asset Utilization
One of the ways to look at asset utilization of Ocean is to check how much profit was generated for every dollar of assets it reports. Ocean Biomedical holds a negative application of assets of -6.82 pct., losing USD0.0682 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Ocean Biomedical shows how discouraging it operates for each dollar spent on its assets.Ocean Biomedical Ownership Allocation
Ocean Biomedical owns a total of 34.65 Million outstanding shares. Ocean Biomedical holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 71.98 pct. of Ocean Biomedical outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Ocean Biomedical Profitability Analysis
Net Loss for the year was (114.47 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ocean Biomedical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ocean Biomedical and how it compares across the competition.
About Ocean Biomedical Valuation
The stock valuation mechanism determines Ocean Biomedical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Ocean Biomedical. We calculate exposure to Ocean Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ocean Biomedical's related companies.Ocean Biomedical Current Valuation Indicators
Valuation refers to the process of determining the present value of Ocean Biomedical and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Ocean we look at many different elements of the entity such as Ocean's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Ocean Biomedical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Ocean Biomedical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Ocean Biomedical's worth.Complementary Tools for Ocean Stock analysis
When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |